Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Editorial: hepatocellular carcinoma in type 2 diabetes: more than meets the eye.
Baffy G.
Am J Gastroenterol. 2012 Jan;107(1):53-5. doi: 10.1038/ajg.2011.390.
Related citations
Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.
Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Sato T, Masuzaki R, Kondo Y, Goto T, Yoshida H, Omata M, Koike K.
Am J Gastroenterol. 2012 Apr;107(4):569-77; quiz 578. doi: 10.1038/ajg.2011.425. Epub 2011 Dec 13.
Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
Lai SW, Chen PC, Liao KF, Muo CH, Lin CC, Sung FC.
Am J Gastroenterol. 2012 Jan;107(1):46-52. doi: 10.1038/ajg.2011.384. Epub 2011 Nov 15.
Bright times for patients with cirrhosis and delayed sleep habits: a case report on the beneficial effect of light therapy.
De Rui M, Gaiani S, Middleton B, Skene DJ, Schiff S, Gatta A, Merkel C, Amodio P, Montagnese S.
Am J Gastroenterol. 2011 Nov;106(11):2048-9. doi: 10.1038/ajg.2011.239. No abstract available.
Rifaximin therapy in minimal hepatic encephalopathy cirrhotics.
Zullo A, Hassan C, Lorenzetti R.
Am J Gastroenterol. 2011 Nov;106(11):2041; author reply 2041-2. doi: 10.1038/ajg.2011.216. No abstract available.
Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.
Kawamura Y, Arase Y, Ikeda K, Seko Y, Imai N, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ohmoto Y, Amakawa K, Tsuji H, Kumada H.
Am J Gastroenterol. 2012 Feb;107(2):253-61. doi: 10.1038/ajg.2011.327. Epub 2011 Oct 18.
Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding.
Augustin S, Altamirano J, González A, Dot J, Abu-Suboh M, Armengol JR, Azpiroz F, Esteban R, Guardia J, Genescà J.
Am J Gastroenterol. 2011 Oct;106(10):1787-95. doi: 10.1038/ajg.2011.173. Epub 2011 May 31.
Hospital readmissions among patients with decompensated cirrhosis.
Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS.
Am J Gastroenterol. 2012 Feb;107(2):247-52. doi: 10.1038/ajg.2011.314. Epub 2011 Sep 20.
Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C.
Sterling RK, Wright EC, Morgan TR, Seeff LB, Hoefs JC, Di Bisceglie AM, Dienstag JL, Lok AS.
Am J Gastroenterol. 2012 Jan;107(1):64-74. doi: 10.1038/ajg.2011.312. Epub 2011 Sep 20.
Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States.
Wan DW, Tzimas D, Smith JA, Kim S, Araujo J, David R, Lobach I, Sarpel U.
Am J Gastroenterol. 2011 Nov;106(11):1994-2000. doi: 10.1038/ajg.2011.302. Epub 2011 Sep 13.
Error occurred: cannot get document summary
Dysplastic Barrett's esophagus in cirrhosis: a treatment dilemma.
Raftopoulos SC, Efthymiou M, May G, Marcon N.
Am J Gastroenterol. 2011 Sep;106(9):1724-6. doi: 10.1038/ajg.2011.174. No abstract available.
Is the lymphoma risk reduced in viral hepatitis? A cirrhotic patient with triple malignancies.
Doganay L, Kiziltas S, Colak Y, Gulluoglu M, Tuncer I.
Am J Gastroenterol. 2011 Sep;106(9):1719-20; author reply 1720. doi: 10.1038/ajg.2011.214. No abstract available.
Losses to follow-up limit conclusions regarding the efficacy of branched-chain amino acids in patients with hepatic encephalopathy.
Mumtaz S, Ford AC.
Am J Gastroenterol. 2011 Sep;106(9):1718; author reply 1718-9. doi: 10.1038/ajg.2011.221. No abstract available.
Lactulose: how many ways can one drug be prescribed?
Lukens B, Nierman DM, Schiano TD.
Am J Gastroenterol. 2011 Sep;106(9):1726-7. doi: 10.1038/ajg.2011.182. No abstract available.
Transplant hepatology training for board certification: 6 months during internal medicine residency and 6 months during gastroenterology fellowship?
Cappell MS.
Am J Gastroenterol. 2011 Aug;106(8):1556-7; author reply 1557-8. doi: 10.1038/ajg.2011.190. No abstract available.
Minimal hepatic encephalopathy and driving: is the genie out of the bottle?
Prakash RK, Brown TA, Mullen KD.
Am J Gastroenterol. 2011 Aug;106(8):1415-6. doi: 10.1038/ajg.2011.154. No abstract available.
Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model.
Kim BK, Kim do Y, Han KH, Park JY, Kim JK, Paik YH, Lee KS, Chon CY, Ahn SH.
Am J Gastroenterol. 2011 Sep;106(9):1654-62, 1730. doi: 10.1038/ajg.2011.160. Epub 2011 Jun 21. Erratum in: Am J Gastroenterol. 2011 Sep;106(9):1730.
Small intestinal bacterial overgrowth and Helicobacter pylori: can they be cause of thrombocytopenia in patients with chronic liver disease?
Savarino E, Assandri L, Giannini EG, Savarino V.
Am J Gastroenterol. 2011 Jun;106(6):1171-2; author reply 1172. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on